The aim of this study was to analyze the prevalence of frailty and physical health limitations among long-term survivors of high-risk neuroblastoma (HR NBL) and to investigate whether frail health is associated with variables of cardiovascular function, markers of inflammation and telomere length. A national study cohort of 19 (median age 22, range 16-30 years) long-term (410 years) HR NBL survivors was studied and the findings were compared with 20 age-and sex-matched controls. Frailty was defined as ⩾ 3 of the following conditions: low muscle mass, low energy expenditure, slow running and weakness. The prevalence of frailty was significantly higher among the HR NBL survivors 9/19 (47%) than among the controls (0%). Thirteen (68%) of the survivors reported significant physical health limitations in vigorous activities, as opposed to none of the controls. The HR NBL survivors had significantly shorter telomere length and higher serum levels of high sensitivity C-reactive protein than did the controls. Frail health and poor physical functioning are prevalent among HR NBL survivors and suggest premature aging. Survivors with gonadal damage, very low fat mass percentage, low glycosylated hemoglobin A1c and increased common carotid artery intima-media thickness may be more prone to early aging after high dose therapy.
INTRODUCTION
The number of childhood cancer survivors is increasing. Currently, the rate of cancer survivors in the population is one in 600 adults up to 40 years. 1 The burden of treatment-related morbidities in the long term remains considerable; cancer survivors are eight times more likely than their siblings to have severe or lifethreatening chronic health conditions. 1 Many young adult survivors report symptoms of impaired fitness, including exercise-induced shortness of breath, 2 fatigue 3 and reduced participation in physical activity. 4 These symptoms may indicate premature aging or frailty. 5 Frailty is a phenotype commonly described in the elderly. 6 It is defined as a clinical syndrome in which three or more of the following criteria are present: unintentional weight loss, selfreported exhaustion, weakness, slow walking and low physical activity. 6 The prevalence of frailty is increased among young adult childhood cancer survivors; this is associated with early morbidity and mortality 5 and likely related to cellular senescence, possibly induced by DNA-damaging cancer therapy. 7 Accordingly, we have recently reported signs of premature arterial aging, asymptomatic cardiac dysfunction, increased blood pressure and poor physical performance among long-term survivors of high-risk neuroblastoma (HR NBL) treated with myeloablative regimens. 8, 9 The objective of this study was to investigate if long-term survivors of HR NBL are more likely than controls to display frail health and physical health limitations. Since short telomeres are known to be indicators of cellular senescence and to associate with increased oxidative stress and inflammation biomarkers, such as high sensitivity C-reactive protein (hsCRP) and TNF-alpha, we further explored if telomere length, markers of inflammation and variables of cardiovascular function can serve as markers of premature aging in young adult survivors of HR NBL treated in early childhood with intensive induction chemotherapy regimens followed by high dose therapy (HDTx) with hematopoietic stem cell support.
MATERIALS AND METHODS Subjects
A national cohort of adult and adolescent long-term survivors of childhood HR NBL was enrolled in this study. The definition of HR NBL was based on the International Neuroblastoma Staging System (INSS) classification system. 10 All patients born in 1996 or earlier and treated at any of the five University Hospitals in Finland (1980 Finland ( -2000 were included. One additional patient with a high-risk retinoblastoma was treated in accordance with the HR NBL protocol and was included in the study. 11 A total of 24 long-term survivors were identified and 20 (83%) of them consented. One of the consented patients died before the initiation of the study due to complications after lung transplantation. Nineteen (79%) patients were included in the final data analysis. Twenty healthy individually age-and sexmatched controls were recruited as controls among medical students and teenage children of hospital employees. The Research Ethics Committee of Helsinki University Hospital approved the study.
Treatment characteristics
HR NBL was diagnosed at a median (± SD) age of 1.7 ±1.1 years (range 0.2-3.9). Conventional chemotherapy was given as described earlier. 8, 9, 12, 13 Low or moderate anthracycline doses were included (median 120 mg/m 2 , 0-210). All patients were consolidated with a HDTx and autologous stem cell transplantation (SCT) (Supplementary Table 1 ). Patients with 1 bone metastases, MYCN amplification and a poor treatment response were given TBI-based HDTx. 12 Ten of the survivors had received fractionated TBI at a median age of 3.1 years (1.4-4.7) and nine received non-TBI-based HDTx at a median age of 1.9 years (1.0-2.9) (P = 0.018). Eighteen survivors had received local radiotherapy (Supplementary Table 1 ). The 19 survivors of HR NBL were assessed at a median age of 22 years (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) . The median follow-up time after the end of therapy was 20 years (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) .
Outcomes
The participants were defined as having frail health if they fulfilled three or more of the following criteria:
Low lean muscle mass. Body composition was measured by dual-energy X-ray absorptiometry (DXA; Hologic Discovery A, Bedford, MA, USA, software version 12.3:3). Study subjects with a lean mass (kg)/height (m) 2 less than − 1.5 SDs from the National Health and Nutrition Examination Study were classified as having low lean muscle mass. 14 Low energy expenditure. The study subjects were interviewed and activity levels were recorded in accordance with the National Health and Nutrition Examination Study. 15 Type, frequency, intensity and duration of activities were converted to kilocalories per week. Men with less than 383 kcal/week and women with less than 270 kcal/week were classified as having low activity. 6 Slowness. Muscular speed was assessed with the shuttle-run test. The subjects ran a 10 × 5 m shuttle run as fast as possible. A shuttle-run test result less than − 1.5 SDs below age-and sex-specific values 16 was classified as slow.
Weakness. Muscular strength was assessed with the sit-up test. The subjects were asked to rise to a sitting position with the knees flexed and ankles supported as many times as possible in 30 s. A test result less than − 1.5 SDs below age-and sex-specific values 16 was classified as weak.
Exhaustion. Self-reported exhaustion was not assessed in this study.
Variables of cardiovascular function
Twenty-four-hour ambulatory blood pressure measurement was performed with an automated monitor (Schiller BR-102 Plus, Schiller AG, Baar, Switzerland) in accordance with the European recommendations. 17, 18 Three-dimensional echocardiography and tissue doppler imaging was performed from standard views as previously described. 19 B-mode ultrasound recordings of the bilateral common carotid, brachial, radial and femoral arteries were obtained with very-high-resolution ultrasound (VHRU, 25-55 MHz) using the Vevo 770 system (Visualsonics, Toronto, ON, Canada). 8 A double-line appearance in the proximity of the lumen-intima interface was assessed when imaging the radial artery with 55 MHz (assessed in all subjects) and in the common femoral artery using 35 MHz (not accessible in all subjects). This was interpreted as a thickened intima layer. All arterial sites were screened for the presence of arterial plaques. Femoral and brachial artery lumen diameters in end-diastole (FALDD and BALDD, respectively) were obtained as described previously. 8 Right arm blood pressure was measured using the GE Carescape Dinamap V100 device. An average of three ultrasound and blood pressure measurements was used for the vascular stiffness calculations. Stiffness index and compliance were calculated as described previously. 8 The results of these measurements in the HR NBL survivors and the controls have been reported previously and were used for further analysis in this study.
Other variables
A detailed history of present health, smoking and physical health limitations, and ongoing endocrine replacement therapies and antihypertensive medications was assessed with a questionnaire. Subject's height and weight were measured.
Blood samples were collected between 0800 and 1000 hours after overnight fasting. Blood level of glycosylated hemoglobin A1c (GHbA1c), plasma levels of total cholesterol, triglycerides and serum levels of insulinlike growth factor 1, hsCRP, TNF-alpha and telomere length were measured. All measurements were performed with standard techniques in the laboratory of Helsinki University Central Hospital. Telomere length analysis was performed at Karolinska Institutet.
Telomere length analysis Total genomic DNA was extracted from peripheral blood (frozen at the time of the study) by using a DNA purification kit (QIAGEN, QIAamp DNA Blood Mid kit, Cat. No 51185). Telomere length was measured by real-time PCR. Briefly, 5 ng of individual DNA was mixed with iQ SYBR Green Supermix (Cat. No 170-8882, Bio-Rad Laboratories, Hercules, CA, USA), and the sample was run in triplicate in a 96-well plate in an iCycler iQ device (Bio-Rad Laboratories). PCR was initiated at 95°C for 3 min (to activate the DNA polymerase), followed by 40 cycles at the following conditions: 95°C for 10 s (denaturation), 60°C for 45 s (annealing/extension) and then 95°C for 60 s and 55°C for 60 s. The fold difference in telomere length was determined by the ΔCT method (Bio-Rad Laboratories) and normalized with hemoglobin subunit gamma-1 (HBG) gene. The primer sequences for Tel 1 and HBG genes were: Tel 1-F: 5′-CGGTTTGTTTGGGTTTGGGT-TTG GGTTTGGGTTTGGGTT-3′; Tel 1-R: 5′-GGCTTGCCTTACCCTTACCCTTACCC-TTACCCTTACCCT-3′. HBG-F: 5′-TGTGCTGGCCCATCACTTTG-3′ and HBG-R: 5′-ACCAGCCA-CCACTTTCTGATAGG-3′, respectively.
Data analysis
All data are presented as median (range). The primary outcomes were frail and non-frail health. The Mann-Whitney U test and Fisher's exact test were used for statistical comparison between survivors and controls as well as between frail and non-frail survivors. Spearman correlation coefficient was used to study associations between telomere length or hsCRP and study parameters. The parameters that correlated significantly with telomere length or hsCRP were further analyzed with simple and multiple linear regressions. Analyses were performed using the IBM SPSS statistical software package (version 22).
RESULTS

Participants
Clinical characteristics of the survivors and controls are described in Table 1 . The NBL survivors had a significantly lower body lean mass adjusted for height (P = 0.001) and a higher trunk (P = 0.014) and body fat mass percentage (P = 0.006). The survivors' body size was smaller. The survivors displayed higher total cholesterol, triglycerides and lower serum levels of insulin-like growth hormone 1 and received more frequently estrogen or testosterone replacement therapy when compared with the controls (Table 1) . Smoking was more common among the survivors than the controls.
Clinical markers of early aging and frailty The survivors reported significantly lower physical activity and more physical health limitations. They were slower in the shuttlerun and the sit-up test than the controls. The different components of frail health (low lean mass, low physical activity, weakness and slowness) were more frequently observed among survivors when compared with controls (Table 2 ). Nine out of 19 survivors fulfilled three or more of the components and were regarded to have frail health. None of the controls had frail health. The prevalence of frail health tended to be higher among TBI recipients (6/10) when compared with those not receiving TBI (3/9) but analysis was limited by small sample size (P = 0.370). However, the survivors who received TBI showed more frequently low physical activity than those treated with chemotherapy-based HDTx. One TBI-treated survivor with four components of frail health died of universal atherosclerosis 2 months after the study.
The relationship of frailty with demographic characteristics, anthropometrics, lifestyle habits, physical condition, self-reported chronic conditions, medical treatments and physical health limitations are shown in Table 1 . The frail survivors had lower total body lean mass (P = 0.007) and lower lean mass adjusted for height (P = 0.018) than the non-frail survivors. They also reported lower kcal expended per week (P = 0.002) and were slower in the shuttle-run test (P = 0.020) ( Table 1) . They were more commonly treated with estrogen or testosterone substitution (8/9 vs 4/10, P = 0.057).
Biomarkers of early aging
The HR NBL survivors had significantly shorter telomeres (median 0.66 arbitrary unit, range 0.24-1.73 vs 0.97, 0.25-3.08; P = 0.043) and significantly higher serum levels of hsCRP (median 2.98, range 0.26-11.39 vs 0.42, 0.11-34.46; P = 0.001) when compared with age-and sex-matched controls ( Table 1 ). The serum level of TNF-alpha did not differ between the survivors and the controls.
Telomere length correlated significantly with low levels of GHbA1c, low total fat mass percentage and low trunk fat mass percentage (Table 3) . Multiple linear regressions were performed to explore the associations between telomere length, GHbA1c and total fat mass percentage. The analysis identified a low GHbA1c (B = 0.249, P = 0.002) as an independent predictor of decreased telomere length. An increased hsCRP correlated significantly with a poor performance in the shuttle-run test, increased carotid intima-media thickness, decreased left ventricular diastolic function and decreased levels of insulin-like growth hormone 1 (Table 3 ). In multiple linear regression analysis, increased common carotid artery intima-media thickness was identified as an independent predictor of increased hsCRP (B = 19.876, P = 0.006).
No correlation with the number of frailty components and telomere length or hsCRP was observed (Table 4) . Telomere length or serum levels of hsCRP were at comparable level in survivors with and without frail health (Table 1) .
DISCUSSION
The present study shows frail health and poor fitness to be prevalent among long-term HR NBL survivors after intensive induction chemotherapy and HDTx with autologous SCT. One half of the survivors fulfilled three or more components of frail health (low lean mass, low physical activity, weakness and slowness), and 80% of them reported that they could not lift heavy objects or run.
The prevalence of frail health (47%) and physical health limitations in vigorous activities (68%) in the present HR NBL cohort with a median age of 22 years was unexpectedly high and suggests significantly accelerated aging. Intensive treatment, including HDTx at a very young age, is a potential factor contributing to the frail health among HR NBL survivors. The survivors received more often estrogen or testosterone replacement therapy but had no more diabetes or anti-hypertensive medication than the controls. Abbreviations: AU = arbitrary unit; BMI = body mass index; BSA = body surface area; CAIMT = carotid artery intima-media thickness; GHbA1c = glycosylated hemoglobin A1c; hsCRP = high sensitivity C-reactive protein; IGF-1 = insulin-like growth factor 1; TBI = total body irradiation; TNF = tumor necrosis factor. Results are reported as median (range).
Aging and frailty in long-term survivors of childhood cancer
We have previously shown that HR NBL survivors treated with TBI display significant signs of premature arterial aging. 8 In the present study, survivors who received TBI showed more frequently low physical activity than survivors treated with chemotherapybased HDTx. Altogether, 60% of TBI recipients were found to have frail health compared with 33% those not receiving TBI but difference did not reach statistical significance. TBI is now rarely used for pre-transplant conditioning to treat HR NBL. To see how generalizable, the present results are to children treated on contemporary regimens, association of frail health and type of HDTx need to be confirmed in larger patient cohorts.
The survivors of HR NBL were shown to have significantly shorter telomere length when compared with age-and sexmatched controls. Telomere length in proliferative tissues declines with cell replication and the effect can be accelerated by factors such as inflammation, oxidative stress, irradiation and toxins. 20 Telomere shortening has previously been reported in buccal cells among survivors of childhood cancer who develop second malignant neoplasms. 21 Reduced telomere length is associated with numerous chronic somatic diseases such as cancer and ischemic heart disease. 20 In the present study, we were unable to Table 2 . The number of components of frail health and physical health limitations among long-term survivors of childhood high-risk neuroblastoma and controls
Components of frailty
Survivors non-TBI (n = 9) N (%) Abbreviations: 3D = three-dimensional echocardiography; BALDD = brachial artery lumen diameter in end-diastole; BMI = body mass index; BP = blood pressure; BSA = body surface area; CACOMP = common carotid artery compliance; CAIMT = common carotid artery intima-media thickness; CASTIF = common carotid artery stiffness index; E = mitral peak velocity in early diastole; E' = early diastolic peak mitral annular velocity; EF = ejection fraction; ESV = end-systolic volume; FALDD = femoral artery lumen diameter in end-diastole; GHbA1c = glycosylated hemoglobin A1c; hsCRP = high sensitivity C-reactive protein; IGF-1 = insulin-like growth factor 1; LVMI = left ventricular mass index; S' = peak myocardial sustained systolic velocity; TDI = tissue doppler imaging. Abbreviations: CAIMT = common carotid artery intima-media thickness; E = mitral peak velocity in early diastole; E' = early diastolic peak mitral annular velocity; GHbA1c = glycosylated hemoglobin A1c; hsCRP = high sensitivity C-reactive protein; IGF-1 = insulin-like growth factor 1.
demonstrate a statistically significant relationship between telomere length and frail health; there were no association with measures of subclinical atherosclerosis, either. The lack of association between early atherosclerosis and telomere length is in line with a recent report from a large cross-sectional cohort of middle-aged population. 22 Multiple linear regression analysis identified low GHbA1c as an independent predictor of decreased telomere length. Low GHbA1c has previously been identified as a marker of poor nutrition in frail persons. 23 Despite a significantly smaller body size, survivors in the present study did not show a poor nutritional status and had higher total fat mass percentage than the controls. However, there was a small subgroup among the survivors with an extremely low total and trunk fat mass percentage and low GHbA1c who also displayed significantly decreased physical health.
Furthermore, we showed an association between increased hsCRP and measures of subclinical atherosclerosis as well as decreased left ventricular function. Multiple linear regression analysis identified an increased common carotid artery intimamedia thickness as an independent predictor of increased hsCRP level. This is well in accordance with previous reports linking sterile inflammation and elevated circulating CRP to early arterial changes, 24 physical disability, 25 obesity and low lean mass. 26, 27 Our observations support the hypothesis that inflammation has an impact on the pathogenesis of early vascular aging. 24 We were not able to show that the frail health defined by specific components might identify survivors at risk for poor cardiovascular health, increased blood pressure or adverse metabolic profiles. However, gonadal damage requiring hormonal replacement therapy was more common among frail than nonfrail survivors. Myeloablative HDTx regimens, irrespectively of the use of TBI, are known to be associated with high-risk gonadal toxicity. 28, 29 Many symptoms of hypogonadism are similar to agerelated changes. It may be difficult to conclude if the association of hormonal replacement therapy and frail health indicates simply a more toxic cancer therapy that the survivors have received or an independent effect on frailty. In other patient cohorts including HIV-infected young males, 30 older women with breast cancer 31 and aging males, 29 gonadal hormone deficiency is known to associate with frailty and poor health status. A small number of studies have suggested that some of these symptoms may be reversed by testosterone or estrogen therapy. 28, 31 Our criteria for frail health differed from those of Fried et al. 6 and from those reported in the St Jude Lifetime Cohort Study. 5 The major limiting factor is that the fifth component of the frailty phenotype, the 'self-reported exhaustion' defined by Fried et al., 6 was missing since questionnaires to classify self-reported exhaustion were not included. Therefore, frailty phenotypes could not be defined and the present results cannot be compared with previously published findings from childhood cancer survivor cohorts. Other limitations are the small sample size that may explain why we failed to show a statistically significant association between subclinical atherosclerosis or cigarette smoking and frailty. However, since 79% of the whole national cohort of survivors was enrolled, we believe that this study series represents long-term HR NBL survivors in general. The small sample size is mainly attributable to the poor prognosis of the HR NBL patients. Major strengths of the study include the population-based design and a comprehensive set of physiologic and metabolic cardiovascular health markers, telomere length and inflammatory markers linked to frailty and physical health limitations.
In conclusion, the adult and adolescent very long-term survivors of childhood HR NBL treated with intensive induction chemotherapy and HDTx with autologous SCT show a high prevalence of frailty and physical health limitations. Those with gonadal damage requiring hormonal replacement therapy, with extremely low fat mass percentage and low GHbA1c or increased common carotid artery intima-media thickness may display an increased risk of premature aging. Future trials for children with HR NBL should focus on identifying the less toxic induction therapy and myeloablative regimens to decrease late adverse effects and to improve quality of life. Application of monoclonal antibodies directed against neuroblastoma cells in the treatment of HR NBL is a step in this direction. 32 As the development of frailty can potentially be influenced by lifestyle choices, a healthy lifestyle, non-smoking and physical activity should be advocated among all long-term survivors of childhood cancer.
